These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1574607)
41. Effects of thyrotropin-releasing hormone analogues on body shaking and prolactin levels in estrogen-primed and nonprimed rats. Yamada K; Kumagai M; Nagashima M; Matsuo N; Furukawa T Arch Int Pharmacodyn Ther; 1989; 297():235-46. PubMed ID: 2499289 [TBL] [Abstract][Full Text] [Related]
42. Regulatory peptides as a source of new drugs--the clinical prospects for analogues of TRH which are resistant to metabolic degradation. Metcalf G Brain Res; 1982 Nov; 257(3):389-408. PubMed ID: 6816389 [TBL] [Abstract][Full Text] [Related]
43. Effect of TRH and DN-1417 on the vestibulo-ocular reflex in squirrel monkeys. Ishii M; Igarashi M; Honda Y Acta Otolaryngol Suppl; 1988; 447():61-6. PubMed ID: 3142205 [TBL] [Abstract][Full Text] [Related]
44. Antinociceptive activity of TRH metabolites in the mouse. Reny-Palasse V; Rips R Pain; 1987 Aug; 30(2):259-269. PubMed ID: 3118323 [TBL] [Abstract][Full Text] [Related]
45. A TRH analog (DN-1417): effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-[14C]glucose method. Nagai Y; Narumi S; Miyamoto M; Saji Y; Nagawa Y Jpn J Pharmacol; 1983 Jun; 33(3):635-45. PubMed ID: 6413736 [TBL] [Abstract][Full Text] [Related]
46. Thyrotropin-releasing hormone (TRH) blocks glucagon-induced hyperglycemia in mice: dissociation of the antihyperglycemic and pituitary actions of TRH. Amir S Brain Res; 1988 Jul; 455(1):201-3. PubMed ID: 3138000 [TBL] [Abstract][Full Text] [Related]
47. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats. Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. Suzuki M; Sugano H; Matsumoto K; Yamamura M; Ishida R J Med Chem; 1990 Aug; 33(8):2130-7. PubMed ID: 2115588 [TBL] [Abstract][Full Text] [Related]
49. Effects of thyrotropin-releasing hormone and a thyrotropin releasing hormone analog on growth and selected plasma hormones in lambs. Muir LA; Wien S J Anim Sci; 1983 Jul; 57(1):139-45. PubMed ID: 6411671 [TBL] [Abstract][Full Text] [Related]
50. Effects of a new TRH analogue, YM-14673 on the central nervous system. Yamamoto M; Shimizu M Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):561-5. PubMed ID: 3125485 [TBL] [Abstract][Full Text] [Related]
51. Effects of thyrotropin-releasing hormone (TRH) and a TRH analogue, MK-771, on punished responding of squirrel monkeys. Brady LS; Valentine JO; Barrett JE Psychopharmacology (Berl); 1984; 83(2):151-4. PubMed ID: 6431464 [TBL] [Abstract][Full Text] [Related]
52. Effects of TRH-T and DN-1417 on the central nervous system: an electrophysiological study of arousal reaction and evoked muscular discharges. Yasuhara M; Naito H Int J Neurosci; 1983 Nov; 21(3-4):197-223. PubMed ID: 6423559 [TBL] [Abstract][Full Text] [Related]
53. A TRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats. Miyamoto M; Narumi S; Nagai Y; Saji Y; Nagawa Y Neuropharmacology; 1984 Jan; 23(1):61-72. PubMed ID: 6425711 [TBL] [Abstract][Full Text] [Related]
54. Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2. Kaur N; Lu X; Gershengorn MC; Jain R J Med Chem; 2005 Sep; 48(19):6162-5. PubMed ID: 16162016 [TBL] [Abstract][Full Text] [Related]
55. Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects. Pekary AE; Stephens R; Simard M; Pang XP; Smith V; DiStefano JJ; Hershman JM Neuroendocrinology; 1990 Dec; 52(6):618-25. PubMed ID: 2126612 [TBL] [Abstract][Full Text] [Related]
56. Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogues. Heal DJ; Stoodley N; Elliott JM; Marsden CA; Bennett GW; Youdim MB Neuropharmacology; 1987 Apr; 26(4):313-22. PubMed ID: 2884590 [TBL] [Abstract][Full Text] [Related]
57. Antiepileptic effects of thyrotropin-releasing hormone and its new derivative, DN-1417, examined in feline amygdaloid kindling preparation. Sato M; Morimoto K; Wada JA Epilepsia; 1984 Oct; 25(5):537-44. PubMed ID: 6434294 [TBL] [Abstract][Full Text] [Related]
58. In vitro and in vivo TSH releasing activity of two new analogues of TRH. Roussel JP; Tapia-Arancibia L; Astier H; Klingler W Acta Endocrinol (Copenh); 1987 Feb; 114(2):314-20. PubMed ID: 3103364 [TBL] [Abstract][Full Text] [Related]
59. Mechanism of the hyperthermic effect of the novel thyrotropin-releasing hormone analogue Na-((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L- prolinamide monohydrate in mice with reserpine-induced hypothermia. Matsushita M; Yonemori F; Ohta A; Iwata K Arzneimittelforschung; 1995 Jun; 45(6):708-11. PubMed ID: 7646576 [TBL] [Abstract][Full Text] [Related]
60. Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents. Yamamoto M; Ozawa Y; Sasamata M; Koshikawa N; Kobayashi M Eur J Pharmacol; 1990 May; 180(2-3):319-24. PubMed ID: 1973117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]